Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
user
  1. Dashboard
  2. My Profile
  3. My Address
  4. My Orders
  5. Acro Membership
Login Register
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP Cytokines Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
There is no goods in the shopping cart !
My Cart|Secure Checkout
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CD39

CD39

Brief Information

Name:Ectonucleoside triphosphate diphosphohydrolase 1
Target Synonym:CD39 Antigen,CD39,EC 3.6.1.5,NTPDase-1,NTPDase 1,ATPDase,SPG64,EC:3.6.1.5,Ecto-ATPase 1,Lymphoid cell activation antigen,ENTPD1,Ectonucleoside Triphosphate Diphosphohydrolase 1,Ecto-ATPDase 1,Ecto-Apyrase,Ecto-ATP diphosphohydrolase 1,EC 3.6.1
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:10
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
CD9-C5PH3 Cynomolgus Cynomolgus CD39 Protein, His Tag (active enzyme, MALS verified)
CD9-C5PH3-structure
CD9-C5PH3-sds
CD9-H82E8 Human Biotinylated Human CD39 (R138A, M139A, E142K) Protein, His,Avitag™ (active enzyme)
CD9-H82E8-structure
CD9-H82E8-sds
CD9-H52H5 Human Human CD39 / ENTPD1 (Q96A, N99A, E143A, R147E) Protein, His Tag (active enzyme, MALS verified)
CD9-H52H5-structure
CD9-H52H5-sds
CD9-H52H7 Human Human CD39 (R138A, M139A, E142K) Protein, His Tag (active enzyme)
CD9-H52H7-structure
CD9-H52H7-sds
CD9-M52H3 Mouse Mouse CD39 / ENTPD2 Protein, His Tag (active enzyme, MALS verified)
CD9-M52H3-structure
CD9-M52H3-sds
CD9-H5253 Human Human CD39 Protein, Mouse IgG2a Fc Tag (active enzyme)
CD9-H5253-structure
CD9-H5253-sds
CD9-H82E5 Human Biotinylated Human CD39 / ENTPD1 Protein, His,Avitag™ (active enzyme)
CD9-H82E5-structure
CD9-H82E5-sds
CD9-H52H4 Human Human CD39 / ENTPD1 Protein, His Tag (active enzyme, MALS verified)
CD9-H52H4-structure
CD9-H52H4-sds
ACRO Quality

Part of Bioactivity data

CD9-H82E8-ELISA
CD39 ELISA

Immobilized Biotinylated Human CD39 (R138A, M139A, E142K) Protein, His,Avitag (Cat. No. CD9-H82E8) at 1 μg/mL (100 μL/well)on streptavidin precoated (Cat. No. STN-N5116) (0.5 μg/well) plate can bind Anti-CD39 Antibody, Human IgG1 with a linear range of 0.1-4 ng/mL (QC tested).

Protocol
CD9-C5PH3-MALS-HPLC
CD39 MALS images

The purity of Cynomolgus CD39 Protein, His Tag (Cat. No. CD9-C5PH3) is more than 85% and the molecular weight of this protein is around 65-85 kDa verified by SEC-MALS.

Synonym Name

CD39,ENTPD1,NTPDase 1,Entpd1,Ecto-ATPDase 1,Ecto-ATPase 1

Background

CD39 is also known as Ectonucleoside triphosphate diphosphohydrolase 1, ENTPD1, NTPDase 1, Ecto-ATPDase 1, in the nervous system, could hydrolyze ATP and other nucleotides to regulate purinergic neurotransmission. Could also be implicated in the prevention of platelet aggregation by hydrolyzing platelet-activating ADP to AMP. Hydrolyzes ATP and ADP equally well. NTPDase-1 was originally described as CD39, a B lymphocyte cell surface marker, but it is also present on the surface of natural killer cells, T cells, and some endothelial cells.Regulatory T cells(Tregs) mediate immunosuppression through multiple, non-redundant, cell-contact dependent and independent mechanisms,  a growing body of evidence suggests an important role for the CD39-CD73-adenosine pathway. CD39 ectonucleotidase is the rate-limiting enzyme of a cascade leading to the generation of suppressive adenosine that alters CD4 and CD8 T cell and natural killer cell antitumor activities.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
TTX-030 TTX-030 Phase 2 Clinical Adimab LLC Solid tumours; Pancreatic Neoplasms; Lymphoma Details
IPH-5201 IPH-5201 Phase 2 Clinical Inserm, Orega Biotech Solid tumours; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung Details
JS-019 JS-019 Phase 2 Clinical Beijing Enrini Biotechnology Co Ltd Solid tumours; Eosinophilia; Lymphoma Details
ES-014 ES-014 Phase 2 Clinical Elpiscience (Shanghai) Biopharma Ltd Solid tumours; Neoplasms Details
Perenostobart SRF-617 Phase 1 Clinical Surface Oncology Inc Solid tumours; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms Details
PUR-001 PUR-001 Phase 1 Clinical Purinomia Biotech Inc Solid tumours Details
AB-598 AB598 Phase 1 Clinical Arcus Biosciences Inc Ovarian Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms Details
AGX-148 AGX-148; AGX148 Phase 1 Clinical AgonOx Inc Squamous Cell Carcinoma of Head and Neck; Neoplasms; Colorectal Neoplasms; Genital Neoplasms, Female; Urogenital Neoplasms; Lung Neoplasms; Melanoma Details
Eurestobart ES-002023 Phase 1 Clinical Elpiscience (Shanghai) Biopharma Ltd Solid tumours Details
ES-002 ES-002 Phase 1 Clinical Elpiscience (Shanghai) Biopharma Ltd Solid tumours; Neoplasms Details
AGX-392 AGX-392 AgonOx Inc Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap